Furthermore, Huang (2018) found that improvement in clinical outcome is resultant of cytosolic HMGB1 triggering dendritic cell maturation through TLR4 activation, whereby consequently recruiting PD-1+ tumor-infiltrating lymphocytes to the tumor site (Huang et al. 2018b). This evidence concerns the gene TLR4 and neoplasm.